Cj. Grossman et al., INHIBITION OF CONSTITUTIVE AND INDUCIBLE CYCLOOXYGENASE ACTIVITY IN HUMAN PLATELETS AND MONONUCLEAR-CELLS BY NSAIDS AND COX-2 INHIBITORS, Inflammation research, 44(6), 1995, pp. 253-257
A range of NSAIDs and reported Cox 2 selective compounds were tested i
n human freshly isolated platelets and LPS-stimulated mononuclear cell
s to determine their potency and selectivity as inhibitors of constitu
tive (presumably Cox 1) and inducible (presumably Cox 2) cyclooxygenas
e respectively. All compounds tested were either equipotent at inhibit
ing constitutive and inducible cyclooxygenase or were selective for th
e inducible form. The most selective compound was Dup697 and the least
selective, ketoprofen. Several compounds only produced a partial inhi
bition of constitutive cyclooxygenase as the maximum inhibitor concent
ration achievable in the assay was limited to 1 mM. With the exception
of paracetamol, all compounds were able to produce full inhibition cu
rves against the inducible form. Potency estimates against constitutiv
e Cox compare closely with published data but most compounds were cons
istently more potent against the inducible isoform than in published d
ata for human cloned, microsomal Cox 2. These data suggest that human
mononuclear cells are either exquisitely sensitive to some NSAIDs or t
hey may contain another Cox isoform as yet indistinguishable from Cox
2.